The clinical role of MDR1 gene expression in human lung cancer

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 721-724

  Oka, Mikio ^a   Fukuda, Minoru ^a   Sakamoto, Akira ^a   Takatani, Hiroshi ^a   Fukuda, Masaaki ^a   Soda, Hiroshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Drug resistance; Lung cancer; MDR1 gene

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CANCER TISSUE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

BLOTTING, NORTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; LUNG NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031044681     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ihde DC: Chemotherapy of lung cancer. N Engl J Med 327: 1434-1441, 1992.
2. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
3. Weinstein RS, Jakute SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB and Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726, 1991.
4. Bradley G, Sharma R, Rajalakshmi S and Ling V: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52: 5154-5161, 1992.
5. Wallner J, Gisslinger H, Gisslinger B, Gsur A, Gotzl M, Zochbauer S and Pirker R: MDR1 gene expression, in chronic lymphocytic leukemia. Leukemia and Lymphoma 13: 333-338, 1994.
6. Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, Allasia C, Horschowski N and Piana L: Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst 86: 1539-1545, 1994.
7. Doyle LA: Mechanisms of drug resistance in human lung cancer cells. Semin Oncol 20: 326-337, 1993.
8. Akiyama S, Fojo AT, Hanover JA, Pastan I and Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple dugs. Somat Cell Mol Genet 11: 117-126, 1985.
9. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
10. World Health Organization: The World Health Organization histological typing of lung tumors. 2nd ed. Am J Clin Pathol 77: 123-136, 1982.
11. Mountain CF: A new international staging system for lung cancer. Chest 89 (Suppl): 225-233, 1986.
12. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
13. Sambrook J, Fritsch EF and Mankitis T: Molecular cloning- a laboratory manual, 2nd ed. New York, Cold Spring Harbor Laboratory Press, 1989.
14. 185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 62: 224-231, 1989.
15. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
16. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
17. Schneider J, Rubio M, Barbazan M, Rodriguez-Escudero FJ, Seizinger BR and Castresana JS: P-glycoprotein. HER2/neu, and mutant p53 expression in human gynecologic tumors. J Natl Cancer Inst 86: 850-855, 1994.
18. Benchimol S and Ling V: P-glycoprotein and tumor progression. J Natl Cancer Inst 56: 814-816, 1994.